XML 21 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:      
Net income $ 11,645 $ 37,193 $ 19,581
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 17,430 15,979 15,421
Provision for losses on accounts receivable 1,841 2,198 2,098
Stock-based compensation expense 6,583 3,162 3,229
Deferred income tax expense (benefit) 3,823 (11,651) 4,855
Amortization of deferred financing costs 532 820 824
Amortization of capitalized commissions on preneed contracts 599 0 0
Accretion of discount on 2.75% convertible subordinated notes 2,192 4,329 3,870
Accretion of discount on 6.625% senior notes 272 0 0
Write off of Deferred Debt Issuance Cost 502 0 567
Net loss (gain) on sale of businesses and disposal of other assets 1,052 (710) 2,077
Impairment of intangible and other assets 1,019 0 145
Changes in operating assets and liabilities that provided (required) cash:      
Accounts and preneed receivables (5,061) (4,254) (5,162)
Inventories and other current assets (159) 1,446 1,995
Intangible and other non-current assets (390) 149 (1,155)
Preneed funeral and cemetery trust investments 24,401 (10,008) (14,528)
Accounts payable 2,044 (3,649) 2,112
Accrued and other liabilities 3,990 (385) 780
Deferred preneed funeral and cemetery revenue 6,546 1,446 (640)
Deferred preneed funeral and cemetery receipts held in trust (29,867) 9,165 13,966
Net cash provided by operating activities 48,994 45,230 50,035
Cash flows from investing activities:      
Acquisitions and land for new construction (37,970) (28,799) (26,556)
Purchase of land and buildings previously leased 0 0 (6,258)
Net proceeds from sale of businesses and other assets 0 5,731 4,385
Capital expenditures (13,526) (16,395) (16,846)
Net cash used in investing activities (51,496) (39,463) (45,275)
Cash flows from financing activities:      
Payments against the term loan (127,500) (11,250) (11,250)
Borrowings from the credit facility 124,500 106,900 71,200
Payments against the credit facility (189,400) (82,600) (96,100)
Borrowings from the term loan 0 0 39,063
Payment of debt issuance costs related to the credit facility 1,751 0 0
Acquisition of 2.75% convertible subordinated notes (98,266) 0 0
Transaction costs related to the acquisition of 2.75% convertible subordinated notes (885) 0 0
Proceeds from the issuance of the 6.625% senior notes 320,125 0 0
Payment of debt issuance costs related to the 6.625% senior notes (1,367) 0 0
Payments on long-term debt and obligations under capital leases (1,940) (1,962) (1,789)
Payments on contingent consideration recorded at acquisition date (138) (101) 0
Proceeds from the exercise of stock options and employee stock purchase plan contributions 1,246 1,496 870
Taxes paid on restricted stock vestings and exercises of non-qualified options (651) (509) (578)
Dividends paid on common stock (5,513) (3,709) (2,492)
Purchase of treasury stock (16,266) (16,366) 0
Payment of loan origination costs related to the credit facility 0 0 (717)
Excess tax deficiency of equity compensation 0 0 (216)
Net cash provided by (used in) financing activities 2,194 (8,101) (2,009)
Net increase (decrease) in cash and cash equivalents (308) (2,334) 2,751
Cash and cash equivalents at beginning of year 952 3,286  
Cash and cash equivalents at end of year 644 $ 952 $ 3,286
Senior Notes [Member]      
Adjustments to reconcile net income to net cash provided by operating activities:      
Amortization of deferred financing costs 100    
Accretion of discount on 6.625% senior notes $ 300